163.76

+1.84%↑

94.62

+2.05%↑

BMO

137.6

+2.33%↑

96.54

+2.97%↑

BNS

70.21

+2.06%↑

163.76

+1.84%↑

94.62

+2.05%↑

BMO

137.6

+2.33%↑

96.54

+2.97%↑

BNS

70.21

+2.06%↑

163.76

+1.84%↑

94.62

+2.05%↑

BMO

137.6

+2.33%↑

96.54

+2.97%↑

BNS

70.21

+2.06%↑

163.76

+1.84%↑

94.62

+2.05%↑

BMO

137.6

+2.33%↑

96.54

+2.97%↑

BNS

70.21

+2.06%↑

163.76

+1.84%↑

94.62

+2.05%↑

BMO

137.6

+2.33%↑

96.54

+2.97%↑

BNS

70.21

+2.06%↑

Home・Aandelen Lijst・Ryan Specialty Holdings Inc

Ryan Specialty Holdings Inc

Open

SectorFinanciën

33.88 1.35

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

32.59

Max

33.98

Belangrijke statistieken
By Trading Economics
Inkomsten	-55M 8M
Verkoop	-3.4M 751M
K/W Sectorgemiddelde	73.596 54.484
EPS	0.45
Dividendrendement	1.38
Winstmarge	1.062
Werknemers	6,110
EBITDA	-58M 171M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+50.71% upside

Dividenden
By Dow Jones
Dividendrendement Sectorgemiddelde	1.38% 4.92%
Volgende Winsten	30 apr 2026
Volgende dividenddatum	26 mei 2026
Volgende Ex Dividend datum	12 mei 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-2.4B 9.1B
Vorige openingsprijs	32.53
Vorige sluitingsprijs	33.88

Nieuwssentiment

By Acuity

50%

171 / 441 Rangschikking in Finance

Technische score

By Trading Central

Vertrouwen

Strong Bullish Evidence

65.38 / 70.93 Steun & Weerstand

Ryan Specialty Holdings Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

31 mrt 2026, 23:31 UTC

Populaire aandelen

Stocks to Watch: Nike, RH, NCino

31 mrt 2026, 22:35 UTC

Winsten

Nike Guides for Sales Declines Ahead as Turnaround Plan Hits Snags -- 2nd Update

1 apr 2026, 00:00 UTC

Acquisities, Fusies, Overnames

The Year Is Off to the Strongest Start for Big Deals Ever -- WSJ

31 mrt 2026, 23:50 UTC

Acquisities, Fusies, Overnames

Nxera Pharma: Partner Centessa Pharmaceuticals to Be Acquired by Lilly >LLY 4565.TO

31 mrt 2026, 23:43 UTC

Marktinformatie

Nikkei May Rise on Hopes for Iran War Ending Soon -- Market Talk

31 mrt 2026, 23:33 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Gold Edges Higher on Signs of De-Escalating Middle East Tensions -- Market Talk

31 mrt 2026, 23:21 UTC

Winsten

Nike Stock Slides on Tariff Impact Despite Earnings Beat; Turnaround Continues -- Barrons.com

31 mrt 2026, 23:14 UTC

Marktinformatie

Winsten

Nike CEO Says Turnaround is Taking Longer Than He'd Like -- Market Talk

31 mrt 2026, 23:12 UTC

Marktinformatie

Aurelia's Cash Flow Strength Highlighted by New Financing Deal -- Market Talk

31 mrt 2026, 22:36 UTC

Winsten

China Vanke 2025 Loss Widens >000002.SZ

31 mrt 2026, 22:36 UTC

Winsten

China Vanke: Increase in Inventory Impariment Provision Among Factors Weighing On Results>000002.SZ

31 mrt 2026, 22:36 UTC

Winsten

China Vanke 2025 Loss CNY88.56B Vs. Loss CNY49.48B >000002.SZ

31 mrt 2026, 22:36 UTC

Winsten

China Vanke: Will Take Time to Resolve Issues Caused by High Debt Levels>000002.SZ

31 mrt 2026, 22:36 UTC

Winsten

China Vanke 2025 Rev CNY233.43B Vs. CNY343.18B >000002.SZ

31 mrt 2026, 21:46 UTC

Acquisities, Fusies, Overnames

Big Drug Companies Hunting for Deals Are Lowering Their Sights -- WSJ

31 mrt 2026, 21:36 UTC

Marktinformatie

West African Resources's Costs Higher Than Bull Expected -- Market Talk

31 mrt 2026, 21:35 UTC

Winsten

Nike Expects China Sales Down 20% in 4Q, CFO Says

31 mrt 2026, 21:35 UTC

Winsten

Nike Expects Modest Growth in North America, Offset by Declines in China, Converse Brand in 4Q, CFO Says

31 mrt 2026, 21:35 UTC

Winsten

Nike Forecasts 4Q Sales Down 2% to 4%, CFO Says

31 mrt 2026, 21:33 UTC

Acquisities, Fusies, Overnames

Biotechs Are a Healthy Growth Bet Thanks to M&A and New Drugs -- Barrons.com

31 mrt 2026, 21:33 UTC

Winsten

Nike Expects Sales Down Low-Single Digits From Now Through End of Calendar Year, CFO Says

31 mrt 2026, 21:32 UTC

Winsten

Nike Expects 1Q to Be Final Quarter Where Tariffs Continue to Be Year-Over-Year Headwind to Margins, CFO Says

31 mrt 2026, 21:28 UTC

Winsten

Nike Expects to End 4Q With Elevated Inventory, CFO Says

31 mrt 2026, 21:26 UTC

Winsten

Nike Increasingly Confident It Will Return to Balanced Growth in North America in Direct, Wholesale Channels, CFO Says

31 mrt 2026, 21:25 UTC

Winsten

Nike Expects Supply-Chain Changes to Pay Off Starting in Fiscal 2027, CFO Says

31 mrt 2026, 21:24 UTC

Marktinformatie

Winsten

Nike: Turnaround Plan Progressing at Different Rates -- Market Talk

31 mrt 2026, 21:22 UTC

Winsten

Nike CFO Expects Football Training and Basketball Will Return to Growth Over Next Few Quarters

31 mrt 2026, 21:22 UTC

Winsten

Nike's Sportswear Business Declined Low-Double Digits in 3Q, CFO Says

31 mrt 2026, 21:21 UTC

Winsten

Nike's Digital Channel Still Too Promotional, CFO Says

31 mrt 2026, 21:20 UTC

Winsten

Nike CEO: Converse Remains Important to Portfolio

Peer Vergelijking

Prijswijziging

Ryan Specialty Holdings Inc Prognose

Koersdoel

By TipRanks

50.71% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 50.85 USD 50.71%

Hoogste 65 USD

Laagste 43 USD

Gebaseerd op 15 Wall Street-analisten die 12-maands prijsdoelen bieden voor Ryan Specialty Holdings Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

15 ratings

Buy

Hold

Sell

Gebaseerd op 15 analisten die aandelenratings hebben gegeven aan Ryan Specialty Holdings Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

65.38 / 70.93Steun & Weerstand

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

All events are bullish.

Sentiment

By Acuity

171 / 441 Rangschikking in Financiën

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Ryan Specialty Holdings Inc

Ryan Specialty Holdings, Inc. operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter. The company serves commercial, industrial, institutional, and government sectors. Ryan Specialty Holdings, Inc. was founded in 2010 and is headquartered in Chicago, Illinois.